One thing we all should have learned from the COVID experience is that not all is well in the land of mass vaccination and we need to rethink our approach to regulatory oversight. Instead of taking a pause, the FDA and CDC are about to blitz us with new approvals based on bad data. We’re joined today by Dr. Meryl Nass, a 42-year internist who is well-studied on all things vaccines. She watched all three days of the CDC’s advisory panel on vaccines recommend approval for so many new vaccines. She explains how the regulatory process works and why it’s corrupt from head to toe. Officials replace real data with fake modeling while ignoring glaring and blaring signals about safety and negative efficacy. COVID was just the tip of the iceberg. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

One thing we all should have learned from the COVID experience is that not all is well in the land of mass vaccination and we need to rethink our approach to regulatory oversight. Instead of taking a pause, the FDA and CDC are about to blitz us with new approvals based on bad data. We’re joined today by Dr. Meryl Nass, a 42-year internist who is well-studied on all things vaccines. She watched all three days of the CDC’s advisory panel on vaccines recommend approval for so many new vaccines. She explains how the regulatory process works and why it’s corrupt from head to toe. Officials replace real data with fake modeling while ignoring glaring and blaring signals about safety and negative efficacy. COVID was just the tip of the iceberg. 

Learn more about your ad choices. Visit megaphone.fm/adchoices